“Clear Evidence” (the highest category) of carcinogenicity
At RF Safe, we want to address the growing concerns surrounding radiofrequency radiation (RFR) and its potential health effects, especially concerning turbo cancer risk. Many in our community are understandably upset by the National Toxicology Program’s (NTP) decision to not pursue further studies over the lack of funding to explore the mechanisms behind the observed effects of RFR.
However, I believe that the necessity for continued studies to “prove an effect” has diminished because this study has been replicated. Evidence is already more than compelling enough to simply say there is a cancer risk and the RFR bioeffect mechanisms are becoming more understood every day because these bioeffects are utilized in medical breakthroughs approved by the FDA in 2023.
The NTP’s findings, along with those from the Ramazzini Institute (RI), have already established clear evidence of carcinogenicity in animal models exposed to RFR. This has been a monumental development in our understanding of non-ionizing radiation. The fact that these findings are being replicated and acknowledged across scientific communities underscores their significance. It’s increasingly clear that every relevant agency must recognize the health risks associated with RFR. Our real problem is captured agencies.
What’s more, the mechanisms for the effects observed are not just theoretical – they are being commercialized and weaponized. For instance, DARPA, an arm of the military-industrial complex has launched the RadioBio initiative, and FDA-approved treatments like TheraBionic, along with the success of the Oncomagnetic device in treating gliomas, have significantly altered our perception of non-ionizing radiation’s effects. These developments in medical technology, which utilize controlled, non-thermal RFR exposures up to 1000 times lower than a cell phone operates to treat aggressive and deadly cancers of the brain and liver, paradoxically validate the concerns regarding uncontrolled, everyday exposure from devices like cell phones that expose users to orders of magnitude more RFR radiation.
The debate over the bioeffects of RFR, in my opinion, is OVER and should now shift from questioning its existence to understanding its full implications and mitigating its risks. The evidence is clear, and no additional study is likely to refute the core findings of the NTP and RI studies. The reality we face is that cell phones, as currently utilized, pose a cancer risk!
As a leader in advocating for RFR safety, my message is not one of fear, but of caution and proactive change. It’s time for the industry and regulators to acknowledge these risks openly and work towards safety advancements. This might include exploring shorter wavelengths or other innovations in wireless technology that can reduce these risks, potentially several wireless generations away before this can be resolved.
The path forward requires a candid acknowledgment of the risks, an embrace of the scientific evidence at hand, and a commitment to innovation and safety in wireless technology. It’s not just about proving a point anymore – it’s about protecting public health and leveraging our understanding of RFR for safer technological advancements.
About the NTP on cell phone radiation
The NTP, the only Federal agency in the US to study the effects of RFR since the 1990s (after the Congress cut off the EPA’s funding for this research), updated its cell phone radiation fact sheet this month to announce that it lacks the resources to continue to study the effects of radiofrequency radiation
The Final Result: The NTP no longer plans to study cell phone radiation even though their 2018 study found “clear evidence” (the highest category) of carcinogenicity in male rats from exposure to cell phone radiation in what is arguably the strongest toxicology study ever conducted on this environmental RFR toxin.
The recent update on the Cellphone Radio Frequency Radiation Studies Fact Sheet by the National Institute of Environmental Health Sciences provides crucial insights into the effects of cellphone radiation. As cellphones are used by 97% of American adults, understanding the potential health risks associated with their use is vital.
January 2024: An updated fact sheet says that the follow-up RFR studies are now ‘complete’. Publication of the results is expected ‘sometime in 2024’. PDF Cellphone Radio Frequency Radiation Studies Fact Sheet
- Study on Rats and Mice: The National Toxicology Program (NTP) conducted extensive studies on rats and mice, focusing on the potential health hazards, including cancer risk from exposure to 2G and 3G cellphone radio frequency radiation (RFR).
- Evidence of Tumors: The studies revealed clear evidence of tumors in the hearts of male rats (malignant schwannomas) and some evidence of tumors in the brains (malignant gliomas) and adrenal glands.
- Gender Differences: The findings showed differences between male and female rats and mice, with male rats appearing more susceptible to tumors.
- Differences in Exposure: While the findings cannot be directly applied to humans due to differences in exposure levels and patterns, they challenge the assumption that low-energy RFR is harmless.
- DNA Damage: The studies also indicated an association between RFR exposure and DNA damage, which could potentially lead to tumors.
- The FDA suggests using speaker mode, reducing cellphone usage time, and preferring texting over talking to minimize RFR exposure.
- The rats and mice were exposed to whole-body RFR at 900 and 1900 megahertz, using both CDMA and GSM technologies.
Relevance to Modern Technologies
- The study’s results specifically pertain to 2G and 3G technologies and do not directly apply to 4G, 5G, or Wi-Fi, which use different signal modulation methods.
The NTP’s comprehensive assessment highlights the need for continued research and awareness regarding the potential health impacts of cellphone radiation. For more detailed information, refer to the full fact sheet on the NTP website.